Clinical Trial Update: A Randomized, Double-Blind, Parallel, Non-Inferiority, Multicenter Trial Evaluate the Efficacy and Safety of UNCNT Compared to MELSMON in Female With Menopausal Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, non-inferiority trial comparing UNCNT to MELSMON in women with menopausal syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopausal Syndrome

Drugs mentioned

• Melsmon (placental extract)
• UNCNT

Snippet

Sponsor: Unimed Pharmaceuticals | Conditions: Menopausal Syndrome | Phase 3 | Status: COMPLETED